# Christophe Hennequin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christophe-hennequin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,661 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 61 |
| i10-index | 231 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5028353199 |
| ORCID iD | https://orcid.org/0000-0002-4528-927X |
| Works | 580 |

## Researcher papers

- [Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2](https://scholariq.org/papers/comparison-of-two-neoadjuvant-chemoradiotherapy-regimens-for-locally-advanced/)
- [Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer](https://scholariq.org/papers/clinical-outcome-of-the-accord-12-0405-prodige-2-randomized-trial-in-rectal/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Fungal Infections and Studies](https://scholariq.org/topics/fungal-infections-and-studies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
